Cetera Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $5.02M | Buy |
5,218
+2,781
| +114% | +$2.68M | 0.04% | 459 |
|
|
2023
Q4 | $2.14M | Buy |
2,437
+72
| +3% | +$63.2K | 0.03% | 479 |
|
|
2023
Q3 | $1.95M | Buy |
2,365
+3
| +0.1% | +$2.47K | 0.03% | 474 |
|
|
2023
Q2 | $1.7M | Buy |
2,362
+175
| +8% | +$126K | 0.03% | 519 |
|
|
2023
Q1 | $1.8M | Buy |
2,187
+8
| +0.4% | +$6.57K | 0.03% | 486 |
|
|
2022
Q4 | $1.57M | Buy |
2,179
+298
| +16% | +$215K | 0.03% | 515 |
|
|
2022
Q3 | $1.3M | Sell |
1,881
-222
| -11% | -$153K | 0.03% | 459 |
|
|
2022
Q2 | $1.24M | Buy |
2,103
+124
| +6% | +$73.3K | 0.03% | 503 |
|
|
2022
Q1 | $1.38M | Buy |
1,979
+56
| +3% | +$39.1K | 0.03% | 507 |
|
|
2021
Q4 | $1.21M | Sell |
1,923
-45
| -2% | -$28.4K | 0.02% | 532 |
|
|
2021
Q3 | $1.19M | Buy |
1,968
+164
| +9% | +$99.3K | 0.02% | 550 |
|
|
2021
Q2 | $1.01M | Sell |
1,804
-10
| -0.6% | -$5.59K | 0.02% | 542 |
|
|
2021
Q1 | $858K | Buy |
1,814
+399
| +28% | +$189K | 0.02% | 540 |
|
|
2020
Q4 | $684K | Buy |
1,415
+880
| +164% | +$425K | 0.02% | 529 |
|
|
2020
Q3 | $299K | Sell |
535
-274
| -34% | -$153K | 0.01% | 728 |
|
|
2020
Q2 | $505K | Sell |
809
-630
| -44% | -$393K | 0.02% | 530 |
|
|
2020
Q1 | $703K | Buy |
+1,439
| New | +$703K | 0.04% | 383 |
|
|
2018
Q4 | – | Sell |
-952
| Closed | -$382K | – | 939 |
|
|
2018
Q3 | $382K | Buy |
+952
| New | +$382K | 0.02% | 652 |
|
|
2015
Q4 | – | Sell |
-743
| Closed | -$347K | – | 756 |
|
|
2015
Q3 | $347K | Buy |
743
+50
| +7% | +$23.4K | 0.03% | 450 |
|
|
2015
Q2 | $359K | Sell |
693
-2
| -0.3% | -$1.04K | 0.03% | 459 |
|
|
2015
Q1 | $316K | Buy |
695
+180
| +35% | +$81.8K | 0.03% | 490 |
|
|
2014
Q4 | $211K | Buy |
+515
| New | +$211K | 0.02% | 587 |
|
|
2013
Q4 | – | Sell |
-670
| Closed | -$210K | – | 520 |
|
|
2013
Q3 | $210K | Buy |
+670
| New | +$210K | 0.04% | 398 |
|